Ph.D. in Immuno-oncology and Virology (in progress)
Tel Aviv, Israel ๐ฎ๐ฑ
Immuno-oncology & Virology
Ph.D. candidate in Immuno-oncology and Virology focused on how signal transduction networks steer the fate of cancer cells during oncolytic virus infection. My work integrates virology, cell biology, and therapeutic context to map the molecular decisions that enable viral oncolysis, stress responses, and anti-tumor effects. I aim to translate these mechanistic insights into strategies that improve oncolytic virotherapy and immuno-oncology outcomes.

Current Focus
Oncolytic virusโcancer interactions
Nationality
India ๐ฎ๐ณ
Latest event
Academic foundations across biotechnology and immuno-oncology.
Tel Aviv, Israel ๐ฎ๐ฑ
Bhubaneswar, India ๐ฎ๐ณ
Translational virology, immunology, and oncolytic virotherapy.
Jan 2017 โ Jul 2019
Translational Health Science and Technology Institute
Faridabad, India ๐ฎ๐ณ
Oct 2017 โ Feb 2019
Translational Health Science and Technology Institute
Faridabad, India ๐ฎ๐ณ
Peer-reviewed work in oncolytic virotherapy and cell fate biology.
Scientific Reports, 2025
Impact Factor: 3.9 (2024)doi:10.1038/s41598-025-08687-8Methods in Molecular Biology, Springer Nature, 2025
doi:10.1007/978-1-0716-4542-0_8Genes (Basel), 2024
Impact Factor: 2.8 (2024)doi:10.3390/genes15091193Laboratory, analytical, and scientific communication expertise.
Conference presentations and scholarly visibility.
Belval, Luxembourg ๐ฑ๐บ
Poster
Tel Aviv-Yafo, Israel ๐ฎ๐ฑ
Flash Talk and Poster
Tel Aviv-Yafo, Israel ๐ฎ๐ฑ
Poster
Competitive awards supporting doctoral training and travel.
Conference travel support
Tel Aviv University funding for doctoral education
Awarded in 2022 and 2023
Funding for doctoral education following a competitive open call
Specialized training for animal research and biosafety handling.